Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2320

1.

Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey.

Kisla Ekinci RM, Balci S, Hershfield M, Bisgin A, Dogruel D, Altintas DU, Yilmaz M.

Rheumatology (Oxford). 2019 Jul 10. pii: kez260. doi: 10.1093/rheumatology/kez260. [Epub ahead of print] No abstract available.

PMID:
31292637
2.

Perinatal outcomes of renal transplant pregnancies: a 22-year experience at a single tertiary referral center.

Hortu I, Arı SA, Akdemir A, Koroglu OA, Yılmaz M, Toz H, Sagol S, Ergenoglu AM.

J Matern Fetal Neonatal Med. 2019 Jul 9:1-7. doi: 10.1080/14767058.2019.1639664. [Epub ahead of print]

PMID:
31288677
3.

Double drainage of pulmonary vein associated with atrial septal defect.

Yılmaz M, Ziadinov E, Aykan HH.

Asian Cardiovasc Thorac Ann. 2019 Jul 9:218492319863600. doi: 10.1177/0218492319863600. [Epub ahead of print] No abstract available.

PMID:
31288550
4.

Intratympanic Steroid Treatment of Bell's Palsy in Patients with Comorbid Disease: A Preliminary Report.

Demir D, Genç S, Güven M, Yılmaz MS, Kara A, Erkorkmaz Ü.

J Int Adv Otol. 2019 Jul 9. doi: 10.5152/iao.2019.5415. [Epub ahead of print]

PMID:
31287437
Free Article
5.

Determination of the relationship between serum anti-mullerian hormone (AMH) level and superovulatory response in Simmental cows.

Sevgi R, Erdem H, Karaşahin T, Yilmaz MA, Satilmiş M, Okuroğlu A, Ünal İ, Dursun Ş, Alkan H, Satilmiş F, Güler M.

Reprod Domest Anim. 2019 Jul 6. doi: 10.1111/rda.13506. [Epub ahead of print]

PMID:
31278782
6.

The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy.

Yilmaz M, Atilla FD, Sahin F, Saydam G.

Support Care Cancer. 2019 Jul 4. doi: 10.1007/s00520-019-04952-5. [Epub ahead of print]

PMID:
31273503
7.

Ureteral access sheath use in retrograde intrarenal surgery.

Karaaslan M, Tonyali S, Yilmaz M, Yahsi S, Tastemur S, Olcucuoglu E.

Arch Ital Urol Androl. 2019 Jul 2;91(2). doi: 10.4081/aiua.2019.2.112.

8.

Response surface methodology as optimization strategy for asymmetric bioreduction of acetophenone using whole cell of Lactobacillus senmaizukei.

Çolak NS, Şahin E, Dertli E, Yilmaz MT, Taylan O.

Prep Biochem Biotechnol. 2019 Jul 1:1-7. doi: 10.1080/10826068.2019.1633668. [Epub ahead of print]

PMID:
31259668
9.

The Novel CHA2DS2-VASC-FSH Score is Predictive of Severe Coronary Artery Disease on Coronary Angiography in Patients with Atrial Fibrillation and Unstable Symptoms.

Ciftci O, Yilmaz KC, Karacaglar E, Yilmaz M, Ozin B, Muderrisoglu IH.

Eurasian J Med. 2019 Jun;51(2):165-171. doi: 10.5152/eurasianjmed.2019.18342.

10.

The Use of Three Different Hemostatic Agents during Laparoscopic Partial Nephrectomy: A Comparison of Surgical and Early Renal Functional Outcomes.

Aykan S, Temiz MZ, Ulus I, Yilmaz M, Gonultas S, Suzan S, Semercioz A, Muslumanoglu AY.

Eurasian J Med. 2019 Jun;51(2):160-164. doi: 10.5152/eurasianjmed.2018.18293.

11.

Anomalous single trunk coronary artery from the right pulmonary artery.

Donmez YN, Aykan HH, Yilmaz M.

Cardiol Young. 2019 Jun 28:1-3. doi: 10.1017/S1047951119001379. [Epub ahead of print]

PMID:
31250782
12.

Is sarcoidosis related to metabolic syndrome and insulin resistance?

Yıldız Gülhan P, Güleç Balbay E, Erçelik M, Yıldız Ş, Yılmaz MA.

Aging Male. 2019 Jun 28:1-6. doi: 10.1080/13685538.2019.1631272. [Epub ahead of print]

PMID:
31250684
13.

Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.

Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, Dogruel D, Karaca NE, Cogurlu MT, Bilir OA, Cansever M, Kapaklı H, Baser D, Kasap N, Kutlug S, Altintas DU, Al-Shaibi A, Agrebi N, Kara M, Guven A, Somer A, Aydogmus C, Ayaz NA, Metin A, Aydogan M, Uncuoglu A, Patiroglu T, Yildiran A, Guner SN, Keles S, Reisli İ, Aksu G, Kutukculer N, Kilic SS, Yilmaz M, Karakoc-Aydiner E, Lo B, Ozen A, Chatila TA, Baris S.

J Allergy Clin Immunol Pract. 2019 Jun 22. pii: S2213-2198(19)30563-X. doi: 10.1016/j.jaip.2019.06.011. [Epub ahead of print]

PMID:
31238161
14.

Predictors for Progression of Tricuspid Insufficiency Following Left-Sided Valvular Surgery: A Retrospective Cohort Study.

Aydın A, Demircin M, Doğan R, Yılmaz M, Paşaoğlu İ.

Heart Surg Forum. 2019 Jun 13;22(3):E262-E268. doi: 10.1532/hsf.2395.

PMID:
31237555
15.

Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib.

Yalniz F, Abou Dalle I, Kantarjian H, Borthakur G, Kadia T, Patel K, Loghavi S, Garcia-Manero G, Sasaki K, Daver N, DiNardo C, Pemmaraju N, Short NJ, Yilmaz M, Bose P, Naqvi K, Pierce S, Nogueras González GM, Konopleva M, Andreeff M, Cortes J, Ravandi F.

Am J Hematol. 2019 Jun 10. doi: 10.1002/ajh.25553. [Epub ahead of print]

PMID:
31237017
16.

Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".

Yilmaz MT, Elmali A, Yazici G.

J Oncol Pharm Pract. 2019 Jun 21:1078155219858177. doi: 10.1177/1078155219858177. [Epub ahead of print] No abstract available.

PMID:
31226918
17.

From DNA Sequencing to Clinical Trials: Finding New Targeted Drugs for Acute Myeloid Leukemia.

Yilmaz M, Daver N.

Drugs. 2019 Jul;79(11):1177-1186. doi: 10.1007/s40265-019-01144-7.

PMID:
31222627
18.

Heparanase is a predictive marker for high thrombus burden in patients with ST-segment elevation myocardial infarction.

Gurbuz AS, Ozturk S, Efe SC, Yılmaz MF, Yanik RE, Yaman A, Kirma C.

Biomarkers. 2019 Jun 19:1-7. doi: 10.1080/1354750X.2019.1628809. [Epub ahead of print]

PMID:
31215255
19.

Comparisons of heart-type fatty acid-binding protein (H-FABP) levels in off-pump versus on-pump coronary artery bypass grafting.

Ulukan MO, Ugurlucan M, Unal O, Yılmaz MF, Kasifoglu N, Sevin MB.

Arch Med Sci Atheroscler Dis. 2019 May 28;4:e119-e125. doi: 10.5114/amsad.2019.85426. eCollection 2019.

20.

The investigation of hyaluronic acid and hyaluronidase -1 levels as tumor marker in larynx cancer.

İnan HC, Yener M, Buyru N, Çelebi A, Yilmaz M, Çomunoğlu N.

Clin Otolaryngol. 2019 Jun 17. doi: 10.1111/coa.13390. [Epub ahead of print]

PMID:
31207115
21.

Partial characterization of a levan type exopolysaccharide (EPS) produced by Leuconostoc mesenteroides showing immunostimulatory and antioxidant activities.

Taylan O, Yilmaz MT, Dertli E.

Int J Biol Macromol. 2019 Jun 13;136:436-444. doi: 10.1016/j.ijbiomac.2019.06.078. [Epub ahead of print]

PMID:
31201910
22.

The Interaction Between Concentration of Heavy Metal-Trace Elements and Non-Smoking Status of Adolescents in Sinop (Turkey).

Cabar HD, Ersoy Karaçuha M, Yilmaz M.

Biol Trace Elem Res. 2019 Jun 13. doi: 10.1007/s12011-019-01769-5. [Epub ahead of print]

PMID:
31197653
23.

Comprehensive multi-technique approach reveals the high diversity of microcystins in field collections and an associated isolate of Microcystis aeruginosa from a Turkish lake.

Yilmaz M, Foss AJ, Miles CO, Özen M, Demir N, Balcı M, Beach DG.

Toxicon. 2019 Jun 7;167:87-100. doi: 10.1016/j.toxicon.2019.06.006. [Epub ahead of print]

PMID:
31181296
24.

A Monostyryl Boradiazaindacene (BODIPY)-based lanthanide-free colorimetric and fluorogenic probe for sequential sensing of copper (II) ions and dipicolinic acid as a biomarker of bacterial endospores.

Cetinkaya Y, Yurt MNZ, Avni Oktem H, Yilmaz MD.

J Hazard Mater. 2019 Sep 5;377:299-304. doi: 10.1016/j.jhazmat.2019.05.108. Epub 2019 May 31.

PMID:
31173979
25.

An advanced c-MET-amplified NSCLC patient that was treated with crizotinib.

Yilmaz M, Mese SG, Cil I, Zirtiloglu A.

J Oncol Pharm Pract. 2019 Jun 2:1078155219851853. doi: 10.1177/1078155219851853. [Epub ahead of print]

PMID:
31156053
26.

Histological Study of The Healing of Traumatic Tympanic Membrane Perforation After Vivosorb and Epifilm Application.

Yilmaz MS, Sahin E, Kaymaz R, Altunkaynak BZ, Akidil AO, Yanar S, Demir D, Guven M.

Ear Nose Throat J. 2019 Jun 2:145561319854320. doi: 10.1177/0145561319854320. [Epub ahead of print]

PMID:
31155945
27.

Effects of current parenteral nutrition treatment on health-related quality of life, physical function, nutritional status, survival and adverse events exclusively in patients with advanced cancer: A systematic literature review.

Tobberup R, Thoresen L, Falkmer UG, Yilmaz MK, Solheim TS, Balstad TR.

Crit Rev Oncol Hematol. 2019 Jul;139:96-107. doi: 10.1016/j.critrevonc.2019.04.014. Epub 2019 Apr 20. Review.

PMID:
31150954
28.

Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia.

Chamoun K, Kantarjian HM, Wang X, Naqvi K, Aung F, Garcia-Manero G, Borthakur G, Jabbour E, Kadia T, Daver N, DiNardo CD, Jain N, Konopleva M, Cortes J, Ravandi F, Yilmaz M.

Cancer. 2019 May 31. doi: 10.1002/cncr.32196. [Epub ahead of print]

PMID:
31150121
29.

URI is required to maintain intestinal architecture during ionizing radiation.

Chaves-Pérez A, Yilmaz M, Perna C, de la Rosa S, Djouder N.

Science. 2019 May 31;364(6443). pii: eaaq1165. doi: 10.1126/science.aaq1165.

PMID:
31147493
30.

Nasogastric Tube Feeding Experiences in Pediatric Oncology Patients and Their Mothers: A Qualitative Study.

Bicakli DH, Sari HY, Yilmaz M, Cetingul N, Kantar M.

Gastroenterol Nurs. 2019 May/Jun;42(3):286-293. doi: 10.1097/SGA.0000000000000385.

PMID:
31145255
31.

Preoperative Low-Molecular-Weight Heparin Prophylaxis Associated with Increased Heparin Resistance Frequency in On-Pump Coronary Artery Bypass Graft Surgery.

Saydam O, Atay M, Serefli D, Doganci S, Kumabasar U, Yılmaz M, Dogan R, Demircin M.

Cardiol Res Pract. 2019 Apr 16;2019:4310407. doi: 10.1155/2019/4310407. eCollection 2019.

32.

Ibrutinib and Venetoclax for First-Line Treatment of CLL.

Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda W.

N Engl J Med. 2019 May 30;380(22):2095-2103. doi: 10.1056/NEJMoa1900574.

PMID:
31141631
33.

Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?

Senturk B, Akdeniz B, Yilmaz MB, Ozcan Kahraman B, Acar B, Uslu S, Birlik M.

Clin Rheumatol. 2019 May 26. doi: 10.1007/s10067-019-04603-4. [Epub ahead of print]

PMID:
31129792
34.

Effect of perinatal biotin deficiency on auditory pathway of the Wistar-Albino rats.

Yılmaz NDS, Gür ÖE, Ensari N, Bulut E, Kaya OT, Sırvancı S, Danısman B, Derin N, Gezgin B, Aygener N, Yılmaz MD.

Acta Otolaryngol. 2019 Aug;139(8):677-684. doi: 10.1080/00016489.2019.1614665. Epub 2019 May 24.

PMID:
31124733
35.

Do Antithymocyte Globulin-Free Acute Rejection Therapies Increase the Risk of Polyoma Nephropathy in Renal Transplant Recipients?

Günay E, Zeytinoğlu A, Şen S, Yılmaz M, Atay G, Aşcı G, Sezer TO, Töz H.

Transplant Proc. 2019 May;51(4):1112-1114. doi: 10.1016/j.transproceed.2019.01.109. Epub 2019 Feb 8.

PMID:
31101182
36.

Investigation of the Factors Affecting Allograft Kidney Functions: Results of 10 Years.

Günay E, Çelebi T, Şen S, Aşcı G, Sarsik Kumbaraci B, Gökalp C, Yılmaz M, Töz H.

Transplant Proc. 2019 May;51(4):1082-1085. doi: 10.1016/j.transproceed.2019.02.014. Epub 2019 Feb 21.

PMID:
31101175
37.

Are calculated ratios and red blood cell and platelet distribution width really important for the laryngeal cancer and precancerous larynx lesions.

Kara A, Guven M, Demir D, Yilmaz MS, Gundogan ME, Genc S.

Niger J Clin Pract. 2019 May;22(5):701-706. doi: 10.4103/njcp.njcp_478_18.

38.

Hyperprogression after nivolumab for melanoma: A case report.

Yilmaz M, Akovali B.

J Oncol Pharm Pract. 2019 May 8:1078155219845436. doi: 10.1177/1078155219845436. [Epub ahead of print]

PMID:
31068087
39.

Can apelin play a role in the etiology of tinnitus

Ensari N, Gür ÖE, Gür N, Selçuk ÖT, Renda L, Yılmaz MD, Öztürk MT, Çekin Y.

Turk J Med Sci. 2019 May 9;49(3). doi: 10.3906/sag-1812-11. [Epub ahead of print]

PMID:
31067839
40.

Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in TURKEY: inferences from GARFIELD-AF registry.

Sayın B, Okutucu S, Yılmaz MB, Özdemir K, Aydınlar A, Şahin DY, Altun A, Açıkel S, Okuyan E, Sucu M, Öngen Z, Ersanlı MK, Yılmaz Ö, Demir M, Pekdemir H, Topsakal R, Şahiner ML, Aras D, Oto A.

Anatol J Cardiol. 2019 Apr;21(5):272-280. doi: 10.14744/AnatolJCardiol.2019.78178.

41.

In Regard to Videtic et al.

Yilmaz MT, Hurmuz P, Cengiz M.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):466-467. doi: 10.1016/j.ijrobp.2019.02.012. No abstract available.

PMID:
31047631
42.

Encapsulation of lipase using magnetic fluorescent calix[4]arene derivatives; improvement of enzyme activity and stability.

Ozyilmaz E, Cetinguney S, Yilmaz M.

Int J Biol Macromol. 2019 Jul 15;133:1042-1050. doi: 10.1016/j.ijbiomac.2019.04.182. Epub 2019 Apr 28.

PMID:
31042560
43.

Long-term results of the Global Modular Replacement System tumor prosthesis for reconstruction after limb-sparing bone resections in orthopedic oncologic conditions: Results from a national cohort.

Yilmaz M, Sørensen MS, Saebye C, Baad-Hansen T, Petersen MM.

J Surg Oncol. 2019 May 1. doi: 10.1002/jso.25490. [Epub ahead of print]

PMID:
31042011
44.

[Bilateral caput femoris epiphysiolysis after epileptic seizures].

Yilmaz M, Andersen JH, Strange-Vognsen HH, Nygaard T.

Ugeskr Laeger. 2019 Apr 15;181(16). pii: V03180158. Danish.

PMID:
31036149
45.

Do practical laboratory indices predict the outcomes of children with Henoch-Schönlein purpura?

Ekinci RMK, Balci S, Sari Gokay S, Yilmaz HL, Dogruel D, Altintas DU, Yilmaz M.

Postgrad Med. 2019 May;131(4):295-298. doi: 10.1080/00325481.2019.1609814. Epub 2019 Apr 25.

PMID:
31021301
46.

Contingencies of UTX/KDM6A Action in Urothelial Carcinoma.

Lang A, Yilmaz M, Hader C, Murday S, Kunz X, Wagner N, Wiek C, Petzsch P, Köhrer K, Koch J, Hoffmann MJ, Greife A, Schulz WA.

Cancers (Basel). 2019 Apr 4;11(4). pii: E481. doi: 10.3390/cancers11040481.

47.

Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis.

Jabbour EJ, Sasaki K, Ravandi F, Short NJ, Garcia-Manero G, Daver N, Kadia T, Konopleva M, Jain N, Cortes J, Issa GC, Jacob J, Kwari M, Thompson P, Garris R, Pemmaraju N, Yilmaz M, O'Brien SM, Kantarjian HM.

Cancer. 2019 Aug 1;125(15):2579-2586. doi: 10.1002/cncr.32139. Epub 2019 Apr 15.

PMID:
30985931
48.

[Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR].

Yılmaz MB, Çelik A, Çavuşoğlu Y, Bekar L, Onrat E, Eren M, Kutlu M, Yalta K, Temizhan A, Kılıçaslan B, Güngör H, Açıkel M, Demir M, Akdemir R, Zoghi M, Tokgözoğlu L.

Turk Kardiyol Dern Ars. 2019 Apr;47(3):198-206. doi: 10.5543/tkda.2019.66877. Turkish.

49.

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts.

Strati P, Garcia-Manero G, Zhao C, Kadia T, Borthakur G, Konopleva M, Daver N, DiNardo CD, Short NJ, Yilmaz M, Naqvi K, Alvarado Y, Pierce SA, Cortes J, Bueso-Ramos C, Kantarjian H, Ravandi F.

Am J Hematol. 2019 Jul;94(7):E188-E190. doi: 10.1002/ajh.25490. Epub 2019 Apr 29. No abstract available.

PMID:
30977182
50.

Nivolumab-induced type 1 diabetes mellitus as an immune-related adverse event.

Yilmaz M.

J Oncol Pharm Pract. 2019 Apr 7:1078155219841116. doi: 10.1177/1078155219841116. [Epub ahead of print]

PMID:
30955467

Supplemental Content

Loading ...
Support Center